Estrogen represses hepatocellular carcinoma (HCC) Growth via Inhibiting Alternative Activation of Tumor-associated Macrophages (TAMs)

Journal of Biological Chemistry

Volumn 287, Issue 48, 2012, Pages 40140-40149

  Yang, Weiwei ^a   Lu, Yan ^a   Xu, Yichen ^a   Xu, Lizhi ^b   Zheng, Wei ^a   Wu, Yuanyuan ^a   Li, Long ^a   Shen, Pingping ^a  

^a NANJING UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HEPATOCARCINOMA; HEPATOCELLULAR CARCINOMA; MALIGNANT CANCERS; MOLECULAR MECHANISM; ORTHOTOPIC; SIGNALING PATHWAYS; TUMOR GROWTH; TUMOR PROGRESSIONS;

DISEASES; MACROPHAGES;

TUMORS;

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE COUPLING FACTOR 6; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INTERLEUKIN 4; JANUS KINASE 1; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; LIVER CELL CARCINOMA; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HUMANS; JANUS KINASE 1; LIVER NEOPLASMS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

MUS;

EID: 84870007806     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.348763     Document Type: Article

References (45)

1. Thomas, M. B., Jaffe, D., Choti, M. M., Belghiti, J., Curley, S., Fong, Y., Gores, G., Kerlan, R., Merle, P., O'Neil, B., Poon, R., Schwartz, L., Tepper, J., Yao, F., Haller, D., Mooney, M., and Venook, A. (2010) Hepatocellular carcinoma. Consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J. Clin. Oncol. 28, 3994-4005
2. Rogers, A. B., Theve, E. J., Feng, Y., Fry, R. C., Taghizadeh, K., Clapp, K. M., Boussahmain, C., Cormier, K. S., and Fox, J. G. (2007) Hepatocellular carcinoma associated with liver-gender disruption in male mice. Cancer Res. 67, 11536-11546
3. Ghebranious, N., and Sell, S. (1998) Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice. Hepatology 27, 383-391 (Pubitemid 28081051)
4. Maeda, S., Kamata, H., Luo, J. L., Leffert, H., and Karin, M. (2005) IKKßcouples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977-990 (Pubitemid 40884391)
5. Bosch, F. X., Ribes, J., Díaz, M., and Cléries, R. (2004) Primary liver cancer. Worldwide incidence and trends. Gastroenterology 127, S5-S16 (Pubitemid 39423365)
6. El-Serag, H. B., Mason, A. C., and Key, C. (2001) Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 33, 62-65 (Pubitemid 32016888)
7. Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., and Karin, M. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124 (Pubitemid 47056470)
8. Nakatani, T., Roy, G., Fujimoto, N., Asahara, T., and Ito, A. (2001) Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin. Jpn. J. Cancer Res. 92, 249-256 (Pubitemid 32288286)
9. CLIP Group (Cancer of the Liver Italian Programme). (1998) Tamoxifen in treatment of hepatocellular carcinoma. A randomized control trial. Lancet 352, 17-20
10. Liu, C. L., Fan, S. T., Ng, I. O., Lo, C. M., Poon, R. T., and Wong, J. (2000) Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors. A prospective randomized study. Am. J. Gastroenterol. 95, 218-222 (Pubitemid 30041563)
11. Condeelis, J., and Pollard, J. W. (2006) Macrophages. Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266 (Pubitemid 43121975)
12. Goswami, S., Sahai, E., Wyckoff, J. B., Cammer, M., Cox, D., Pixley, F. J., Stanley, E. R., Segall, J. E., and Condeelis, J. S. (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65, 5278-5283 (Pubitemid 40827339)
13. Bingle, L., Brown, N. J., and Lewis, C. E. (2002) The role of tumor-associated macrophages in tumor progression. Implications for new anticancer therapies. J. Pathol. 196, 254-265 (Pubitemid 34189413)
14. Lin, E. Y., Nguyen, A. V., Russell, R. G., and Pollard, J. W. (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740
15. Pollard, J. W. (2004) Tumor-educated macrophages promote tumor progression and metastasis. Nat. Rev. Cancer 4, 71-78
16. Lin, E. Y., Gouon-Evans, V., Nguyen, A. V., and Pollard, J. W. (2002) The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J. Mammary Gland Biol. Neoplasia 7, 147-162 (Pubitemid 38420772)
17. Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H., Ballmer-Hofer, K., and Schwendener, R. A. (2006) Clodronate-liposome-mediated depletion of tumor-associated macrophages. A new and highly effective antiangiogenic therapy approach. Br. J. Cancer 95, 272-281 (Pubitemid 44187587)
18. Mantovani, A., Porta, C., Rubino, L., Allavena, P., and Sica, A. (2006) Tumor-associated macrophages (TAMs) as new target in anticancer therapy. Drug Discov. Today 3, 361-366 (Pubitemid 44774479)
19. Pollard, J. W. (2009) Trophic macrophages in development and disease. Nat. Rev. Immunol. 9, 259-270
20. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. (2002) Macrophage polarization. Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555 (Pubitemid 35223554)
21. Mantovani, A., and Sica, A. (2010) Macrophages, innate immunity, and cancer. Balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231-237
22. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B., Doni, A., Vincenzo, B., Pasqualini, F., Vago, L., Nebuloni, M., Mantovani, A., and Sica, A. (2006) A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122 (Pubitemid 43289397)
23. Pucci, F., Venneri, M. A., Biziato, D., Nonis, A., Moi, D., Sica, A., Di Serio, C., Naldini, L., and De Palma, M. (2009) A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident"monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114, 901-914
24. Ojalvo, L. S., King, W., Cox, D., and Pollard, J. W. (2009) High density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am. J. Pathol. 174, 1048-1064
25. Bao, X., Cui, J., Wu, Y., Han, X., Gao, C., Hua, Z., and Shen, P. (2007) The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages. J. Mol. Med. 85, 85-98 (Pubitemid 46020945)
26. Qian, B. Z., and Pollard, J. W. (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51
27. + T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91-102
28. Gocheva, V., Wang, H. W., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T., and Joyce, J. A. (2010) IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 24, 241-255
29. Yang, S. H., Sarkar, S. N., Liu, R., Perez, E. J., Wang, X., Wen, Y., Yan, L. J., and Simpkins, J. W. (2009) Estrogen receptor β as a mitochondrial vulnerability factor. J. Biol. Chem. 284, 9540-9548
30. Hoenerhoff, M. J., Pandiri, A. R., Lahousse, S. A., Hong, H. H., Ton, T. V., Masinde, T., Auerbach, S. S., Gerrish, K., Bushel, P. R., Shockley, K. R., Peddada, S. D., and Sills, R. C. (2011) Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice. Similarities in the molecular landscape with human liver cancer. Toxicol. Pathol. 39, 678-699
31. Xu, H., Wei, Y., Zhang, Y., Xu, Y., Li, F., Liu, J., Zhang, W., Han, X., Tan, R., and Shen, P. (2012) Estrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol. 228, 216-229
32. Yao, X., Hu, J. F., Daniels, M., Yien, H., Lu, H., Sharan, H., Zhou, X., Zeng, Z., Li, T., Yang, Y., and Hoffman, A. R. (2003) A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis. Clin. Cancer Res. 9, 2719-2726 (Pubitemid 36842118)
33. Lu, Y. S., Kashida, Y., Kulp, S. K., Wang, Y. C., Wang, D., Hung, J. H., Tang, M., Lin, Z. Z., Chen, T. J., Cheng, A. L., and Chen, C. S. (2007) Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma. Hepatology 46, 1119-1130 (Pubitemid 350144776)
34. de Visser, K. E., Eichten, A., and Coussens, L. M. (2006) Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6, 24-37 (Pubitemid 43053650)
35. Albini, A., Magnani, E., and Noonan, D. M. (2010) The tumor microenvironment. Biology of a complex cellular and tissue society. Q. J. Nucl. Med. Mol. Imaging 54, 244-248
36. Barajas, M., Mazzolini, G., Genové, G., Bilbao, R., Narvaiza, I., Schmitz, V., Sangro, B., Melero, I., Qian, C., and Prieto, J. (2001) Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology 33, 52-61 (Pubitemid 32016887)
37. Ding, T., Xu, J., Wang, F., Shi, M., Zhang, Y., Li, S. P., and Zheng, L. (2009) High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum. Pathol. 40, 381-389
38. Ohmori, Y., and Hamilton, T. A. (1998) STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J. Biol. Chem. 273, 29202-29209 (Pubitemid 28507621)
39. Lu, X., Malumbres, R., Shields, B., Jiang, X., Sarosiek, K. A., Natkunam, Y., Tiganis, T., and Lossos, I. S. (2008) PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. Blood 112, 4098-4108
40. Myers, M. P., Andersen, J. N., Cheng, A., Tremblay, M. L., Horvath, C. M., Parisien, J. P., Salmeen, A., Barford, D., and Tonks, N. K. (2001) TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276, 47771-47774
41. Dickensheets, H., Vazquez, N., Sheikh, F., Gingras, S., Murray, P. J., Ryan, J. J., and Donnelly, R. P. (2007) Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling. Genes Immun. 8, 21-27 (Pubitemid 46158099)
42. Vivar, O. I., Zhao, X., Saunier, E. F., Griffin, C., Mayba, O. S., Tagliaferri, M., Cohen, I., Speed, T. P., and Leitman, D. C. (2010) Estrogen receptor βbinds to and regulates three distinct classes of target genes. J. Biol. Chem. 285, 22059-22066
43. Pettersson, K., and Gustafsson, J. A. (2001) Role of estrogen receptor β in estrogen action. Annu. Rev. Physiol. 63, 165-192
44. 1-ATP synthase. J. Biochem. 149, 655-664
45. Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., Costa, S., Vinckier, S., Dresselaer, T., Åkerud, P., De Mol, M., Sälomaki, H., Phillipson, M., Wyns, S., Larsson, E., Buysschaert, I., Botling, J., Himmelreich, U., Van Ginderachter, J. A., De Palma, M., Dewerchin, M., Claesson-Welsh, L., and Carmeliet, P. (2011) HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through down-regulation of PlGF. Cancer Cell 19, 31-44